69
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease

, , &
Pages 909-915 | Published online: 12 May 2015

References

  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed January 15, 2014
  • National Heart, Lung, and Blood InstituteMorbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases Available at: https://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdfAccessed April 23, 2015
  • MiniñoAMXuJKochanekKDDeaths: Preliminary data for 2008Natl Vital Stat Rep201059215225073655
  • AnderssonFBorgSJanssonSAThe costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respir Med200296970070812243316
  • VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
  • CalverleyPMRabeKFGoehringUMKristiansenSFabbriLMMartinezFJRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet2009374969168569419716960
  • FabbriLMCalverleyPMIzquierdo-AlonsoJLRoflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsLancet2009374969169570319716961
  • US Food and Drug AdministrationFDA approves new drug to treat chronic obstructive pulmonary disease Available from: http://www.fda.gov/NewsEvents/newsroom/PressAnnouncements/ucm244989.htmAccessed April 16, 2015
  • BayeJRoflumilast (Daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary diseaseP T201237314916122605906
  • ZhaoYAshASEllisRPPredicting pharmacy costs and other medical costs using diagnoses and drug claimsMed Care2005431344315626932
  • FuAZChenLSullivanSDChristiansenNPAbsenteeism and short-term disability associated with breast cancerBreast Cancer Res Treat2011130123524221567238
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • LindenauerPKPekowPSLahtiMCLeeYBenjaminEMRothbergMBAssociation of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary diseaseJAMA2010303232359236720551406
  • MapelDWDutroMPMartonJPWoodruffKMakeBIdentifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims dataBMC Health Serv Res2011114321345188
  • ParsonsLSReducing bias in a propensity score matched-pair sample using greedy matching techniquesPaper 214-26 presented at the SAS Users Group 26th International ConferenceLong Beach, CA, USAApril 22–25, 2001
  • MackTMPikeMCHendersonBEEstrogens and endometrial cancer in a retirement communityN Engl J Med19762942312621267177870
  • FieldSKRoflumilast, a novel phosphodiesterase 4 inhibitor, for COPD patients with a history of exacerbationsClin Med Insights Circ Respir Pulm Med20115577022084617
  • Van de GriendJPMarcumZALinneburSAA year in review: new drugs for older adults in 2011Am J Geriatr Pharmacother201210425826322682643
  • WedzichaJARabeKFMartinezFJEfficacy of roflumilast in the COPD frequent exacerbator phenotypeChest201314351302131123117188
  • No authors listedRoflumilast: doubtful efficacy but clear harms in COPDPrescrire Int2013221345923367674
  • JenkinsCRCelliBAndersonJASeasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyEur Respir J2012391384521737561
  • VilkmanSKeistinenTTuuponenTKivelaSLSeasonal variation in hospital admissions for chronic obstructive pulmonary disease in FinlandArctic Med Res19965541821869115544
  • SuissaSImmortal time bias in pharmaco-epidemiologyAm J Epidemiol2008167449249918056625
  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO workshop reportBethesdaNational Heart, Lung and Blood Institute2008 Available from: http://www.goldcopd.org/uploads/users/files/GOLDWkshp05Clean.pdfAccessed April 16, 2015